new IV immune globulin called RespiGam

March 1996

You'll see a new IV immune globulin called RespiGam...formulated to PREVENT Respiratory Syncytial Virus (RSV) disease in children.

RSV is the leading cause of pneumonia in infants. Those at highest risk are premature infants...and children under age two with bronchopulmonary dysplasia (BPD).

Although RSV isn't increasing in incidence, it's being recognized and diagnosed more often.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote